WallStSmart
ACAD

ACADIA Pharmaceuticals Inc

NASDAQ: ACAD · HEALTHCARE · BIOTECHNOLOGY

$22.20
-2.07% today

Updated 2026-04-29

Market cap
$3.80B
P/E ratio
9.65
P/S ratio
3.55x
EPS (TTM)
$2.30
Dividend yield
52W range
$14 – $28
Volume
1.9M

ACADIA Pharmaceuticals Inc (ACAD) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-41.42M$-54.93M$-64.87M$-13.73M$-10.70M$-19.90M$-21.63M$-31.77M$-66.43M$-121.80M$-210.41M$-217.86M$-167.47M$-151.13M$-136.17M$-125.66M$-114.03M$16.70M$157.72M$109.84M
Capital expenditures$2.03M$416000.00$226000.00$41000.00$0.00$3000.00$3000.00$618000.00$180000.00$2.14M$9.51M$812000.00$2.15M$1.13M$7.59M$1.12M$0.00$40.05M$523000.00$4.69M
Depreciation
Stock-based comp$3.38M$3.38M$2.99M$2.13M$1.58M$1.60M$1.93M$5.71M$16.04M$40.19M$55.27M$75.53M$81.56M$82.27M$84.42M$63.62M$68.20M$66.42M$67.05M$52.13M
Free cash flow$-43.44M$-55.34M$-65.09M$-13.77M$-10.70M$-19.90M$-21.64M$-32.39M$-66.61M$-123.94M$-219.91M$-218.67M$-169.62M$-152.26M$-143.75M$-126.78M$-114.03M$-23.35M$157.20M$105.15M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$40000.00$51.01M$-46.19M$50.15M$40.28M$61.48M$-94.20M$67.69M$54.88M$137.34M$-178.60M